Platelet aggregability in patients with hypertension treated with angiotensin II type 1 receptor blockers

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 1, 2007, Pages 31-35

  Sato, Yuki ^a   Fujii, Satoshi ^a   Imagawa, Shogo ^a   Ohmura, Kazue ^a   Ohmura, Yoshinori ^a   Andoh, Yasuhiro ^a   Dong, Jie ^a   Ishimori, Naoki ^a   Furumoto, Tomoo ^a   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; High blood pressure; Thrombosis; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BENZIMIDAZOLE DERIVATIVE; CANDESARTAN; LOSARTAN; TETRAZOLE DERIVATIVE;

AGED; ARTICLE; BLOOD; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; LIGHT; MALE; PHARMACOKINETICS; RADIATION SCATTERING; THROMBOCYTE AGGREGATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; LIGHT; LOSARTAN; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; SCATTERING, RADIATION; TETRAZOLES; THERAPEUTIC EQUIVALENCY;

EID: 34249859312     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.14.31     Document Type: Article

References (23)

1. Nadar SK, Blann AD, Kamath S, Beevers DG, and Lip GY: Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol, 2004; 44:415-422
2. Lip GY, Edmunds E, Hee FL, Blann AD, and Beevers DG: A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens, 2001; 14:823-828
3. Pieston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, and Ahn YS: Effects of severe hypertension on endothelial and platelet microparticles. Hypertension, 2003; 41:211-217
4. Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Shimomara H, Kojima S, Hokamaki J, Sugiyama S, Hirai N, Yoshimura M, Ozaki Y, and Ogawa H: For mation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost, 2003; 89:681-686
5. Sasaki H, Kanai S, Oyama T, Miyashita Y, Yamamura S, and Shirai K: Effect of combination therapy of benidipine hydrochloride and candesartan cilexetil on serum lipid metabolism and blood pressure in elderly hypertensive patients with type 2 diabetes mellitus. J Atheroscler Thromb, 2006; 13:149-157
6. Miyashita Y, Ito Y, Hasiguchi S, Totsuka M, Aoki A, Kurokawa M, Tomioka H, and Shirai K: Effect of temocapril hydrochloride on serum lipid levels in patients with hypertensive type 2 diabetes mellitus. J Atheroscler Thromb, 2001; 8:25-29
7. Kramer C, Sunkomat J, Witte J, Luchtefeld M, Walden M, Schmidt B, Tsikas D, Boger RH, Forssmann WG, Drexler H, and Schieffer B: Angiotensin II receptor-independent andiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. Circ Res, 2002; 90:770-776
8. Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, and Kume S: Detection of platelet aggregates with an article counting method using light scattering. Analytical Biochemistry, 1994; 218:284-294
9. Tohgi H, Takahashi H, Watanabe K, Kuki H, and Shirasawa Y: Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication. Thromb Haemost, 1996; 75:838-843
10. Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 1962; 19:927-929
11. Cardinal DC and Flower RJ: The electronic aggregometer: A novel device for assessing platelet behavior in blood. J Pharmacol Methods, 1980; 3:135-158
12. Guerra-Cuesta JI, Monton M, Rodriguez-Feo JA, Jimenez AM, Gonzalez-Fernandez F, Rico LA, Garcia R, Gomez J, Farre J, Casado S, and Lopez-Farre A: Effect of losartan on human platelet activation. J Hypertens, 1999; 17:447-452
13. Monton M, Jimenez A, Nunez A, Lopez-Blaya A, Farre J, Gomez J, Zalba LR, Sanchez de Miguel L, Casado S, and Lopez-Farre A: Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation. J Cardiovasc Pharmacol, 2000; 35:906-913
14. Levy PJ, Yunis C, Owen J, Brosnihan KB, Smith R, and Ferrario CM: Inhibition of platelet aggregability by losartan in essential hypertension. Am J Cardiol, 2000; 86:1188-1192
15. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S, and Iwasaka T: Losartan and simvastatin inhibit platelet activation in hypertensive patients. J Thromb Thrombolysis, 2004; 18:177-185
16. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, and Devereux RB: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol, 2005; 45:712-719
17. Roth GJ and Majerus PW: The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest, 1975; 56:624-632
18. Hasegawa Y. Yamaguchi T, Omae T, Woodward M, and Chalmers J; PROGRESS CT Substudy Investigators. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. Hypertens Res, 2004; 27:147-156
19. Suzuki H and Kanno Y; Efficacy of Candesartan on Outcome in Saitama Trial (E-COST) Group. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Hypertens Res, 2005; 28:307-314
20. Faraday N, Goldschmidt-Clermont PJ, and Bray PF: Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost, 1997; 77:748-754
21. Nies AS, Andros EA, and Gerber JG: Platelet α2-adrenergic receptor responsiveness is increased in elderly men but not in elderly women. Clin Pharmacol Ther, 1992; 52:605-608
22. Neuger J, El Khoury A, Kjellman BF, Wahlund B, Aberg-Wistedt A, and Stain-Malingren R: Platelet serotonin functions in untreated major depression. Psychiatry Res, 1999; 85:189-198
23. Oku N, Kitagawa K, Imaizurni M, Takasawa M, Piao R, Kimura Y, Kajimoto K, Matsumoto M, Hori M, and Hatazawa J: Hemodynamic influences of losartan on the brain in hypertensive patients. Hypertens Res, 2005; 28:43-49